| abstract |
Evaluate biomarkers for diagnostic, treatment-related or prognostics to identify phenotypes, such as disease state or disease or disease stage or progression, and for disease, disease state, disease stage and disease stage Candidate treatment regimens can be selected and the therapeutic effect determined. Circulating biomarkers from body fluids can be used for profiling physiological states or determining phenotypes. These include nucleic acids, proteins and circulating structures such as vesicles and nucleic acid-protein complexes. |